Allergan Inc. Comments On California Federal Court Ruling In Insider Trading Lawsuit Against Valeant & Pershing Square

IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE: AGN) (“Allergan” or the “Company”) today commented on the ruling in the United States District Court for the Central District of California in the Company’s federal securities litigation against Valeant Pharmaceuticals International, Inc. (“Valeant”), Pershing Square Capital Management, L.P. (“Pershing Square”) and its principal, William A. Ackman.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC